Vitamin D3 and K2 Benefits for Endurance Athletes (2026)

Vitamin D3 and K2 are two fat-soluble nutrients that most athletes know by name but rarely understand as a system. Taken separately, each provides distinct benefits. Taken together, they form one of the most evidence-supported foundational stacks for anyone training year-round, because D3 drives calcium absorption while K2 determines where that calcium actually goes.

This guide covers the clinical evidence, practical dosing, and the specific ways D3 and K2 affect muscle performance, bone integrity, and energy metabolism for endurance athletes.

What Are the Benefits of Vitamin D3 and K2 Together?

Vitamin D3 dramatically increases calcium absorption from the gut, but without sufficient K2 (as MK-7), the excess calcium can deposit in soft tissue and arterial walls rather than bone. The synergistic benefit of combining D3 and K2 is that D3 elevates circulating calcium and activates calcium-regulating proteins, while K2 activates osteocalcin and matrix GLA protein (MGP), which shuttle calcium into bone and actively suppress arterial calcification. A 2019 review in Nutrients confirmed that co-supplementation produces bone mineral density gains superior to D3 supplementation alone.

When D3 is taken without K2, chronically elevated calcium absorption without proper routing creates a net risk. MGP, the protein responsible for preventing vascular calcium deposits, is vitamin K2-dependent. Athletes who supplement D3 long-term at doses of 3,000 IU or more should pair it with at least 100 mcg MK-7 daily to keep MGP carboxylated and functional.

The practical takeaway: D3 raises the supply of calcium available to the body; K2 is the traffic controller that sends it to bone instead of arteries.

Why Endurance Athletes Need Higher Vitamin D

Endurance athletes have a higher physiological demand for vitamin D than the general population because of increased bone turnover, elevated immune stress from high training loads, and the practical reality that most athletes train before sunrise or in winter months when UV-B intensity is too low to drive meaningful skin synthesis. Vitamin D deficiency is directly associated with stress fractures in runners and with measurable reductions in muscle force output, both of which undermine training capacity before symptoms appear.

Studies in military personnel and competitive runners have found that serum 25-OH-D levels below 30 ng/mL correlate with a 2 to 4 times higher stress fracture incidence compared to athletes at 40 ng/mL or above. For context, the US adult population averages around 25 to 30 ng/mL, which places many athletes below the threshold that supports optimal bone remodeling under load.

Athletes training outdoors in northern latitudes (above 35 degrees north) receive negligible UV-B-driven vitamin D synthesis from October through March regardless of time spent outside. Indoor training compounds this. Sweat loss does not directly deplete vitamin D (it is not sweat-soluble), but the combination of high training volume and limited sun exposure makes dietary and supplement sources the only reliable pathway.

Most endurance athletes benefit from 2,000 to 5,000 IU of D3 daily, with the higher end appropriate during winter months or for athletes who train primarily indoors. The target serum level for athletes is 40 to 60 ng/mL of 25-OH-D, a range associated with optimal muscle function and immune competence. Testing once or twice per year is the only reliable way to confirm sufficiency, since skin tone, body composition, and geography all affect conversion rates.

The Difference Between K1 and K2 (MK-4 vs MK-7)

Vitamin K1 (phylloquinone) is found in leafy greens and functions primarily in blood coagulation in the liver. Vitamin K2 (menaquinone) operates in peripheral tissues, including bone and arterial walls, where it activates the calcium-routing proteins osteocalcin and MGP. For athletes, K2 is the relevant form. Between the two main K2 subtypes, MK-7 has a plasma half-life of approximately 72 hours compared to MK-4's 1 to 4 hours, making MK-7 more effective at sustaining active K2 levels with once-daily dosing.

The half-life difference is clinically significant. MK-4 at typical supplement doses (1,500 mcg) has been used in Japanese osteoporosis trials, but it requires multiple daily doses to maintain tissue saturation. MK-7 at 100 to 200 mcg once daily produces steady-state plasma levels that are 7 to 8 times higher than equivalent MK-4 doses, based on pharmacokinetic data published in the British Journal of Nutrition (2013).

For endurance athletes adding K2 to a D3 regimen, MK-7 sourced from natto or fermented chickpeas is the preferred form. Most supplement labels listing "vitamin K2 as MK-7" at 100 to 200 mcg meet the dose range supported by bone density research.

K1 from dietary sources does not meaningfully address the calcium-routing function. Athletes eating plenty of leafy greens get adequate K1 for clotting but should not assume it substitutes for K2 MK-7 in a D3 stack.

How D3 and K2 Affect Muscle Function and Performance

Vitamin D3 receptors (VDR) are expressed in skeletal muscle tissue, and activation of these receptors supports protein synthesis, fast-twitch fiber recruitment, and mitochondrial respiration. Low vitamin D is independently associated with reduced VO2 max in trained athletes, with a 2010 study in Medicine and Science in Sports and Exercise finding that each 10 ng/mL increase in serum 25-OH-D correlated with a measurable improvement in cardiorespiratory fitness markers. K2's role in muscle metabolism is emerging, with early data suggesting mitochondrial electron transport chain support, though this evidence is less established than the D3 research.

The D3-muscle connection is mechanistically well-documented. VDR activation in myocytes upregulates genes involved in calcium handling and contractile force. Athletes with serum 25-OH-D below 30 ng/mL frequently report vague leg fatigue and reduced power output at threshold, symptoms that resolve after correcting deficiency, typically over 8 to 12 weeks of supplementation.

For K2 and muscle performance, the evidence base is newer. Animal models and small human trials suggest that MK-7 supports mitochondrial membrane integrity and may reduce exercise-induced oxidative stress in muscle tissue. This is plausible given K2's fat-soluble antioxidant properties, but athletes should weight this evidence appropriately: it is preliminary and should not drive dosing decisions independent of the well-established bone and cardiovascular benefits.

The practical implication for endurance athletes: correcting D3 deficiency has a measurable, reproducible effect on training capacity. Adding K2 MK-7 alongside D3 is primarily about bone and cardiovascular safety, with a secondary, less certain effect on muscle metabolism.

Vitamin D3 and K2 for Bone Health in High-Impact Athletes

Stress fractures are the most preventable severe injury in running and triathlon, and vitamin D status is one of the most modifiable risk factors. Research in the American Journal of Clinical Nutrition found that combined D3 and K2 supplementation over 12 months produced significantly greater gains in femoral neck bone mineral density than D3 supplementation alone, with the K2 group showing a 1.3% higher BMD gain at the clinically relevant hip measurement site.

High running mileage increases bone remodeling turnover. During periods of high turnover, calcium availability and proper routing both matter. If D levels are low, remodeling cannot keep pace with impact stress. If K2 is low, the calcium being absorbed from a corrected-D3 state may not reach bone at adequate rates.

Female endurance athletes face a compounded risk. The female athlete triad (low energy availability, menstrual dysfunction, and low bone density) creates a context where D3 and K2 are not optional extras but core interventions. Even without full triad presentation, female athletes in heavy training commonly exhibit bone turnover markers that indicate net bone loss during intense training blocks. D3 at 2,000 to 5,000 IU and K2 MK-7 at 100 to 200 mcg daily, combined with adequate dietary calcium (1,000 to 1,300 mg), represent the foundational nutritional support for bone integrity.

Male athletes are not exempt. Long-course triathletes and ultramarathon runners show stress fracture rates comparable to female runners in some studies, particularly at the metatarsals and tibial shaft. Training volume rather than sex is the primary driver of fracture risk in highly trained male athletes, and vitamin D status modifies that risk in the same direction.

Dosing and Timing: How to Take D3 and K2

Both vitamin D3 and K2 are fat-soluble, meaning they require dietary fat present in the gut at the time of ingestion for efficient absorption. Take both with a meal that contains at least 10 to 15 grams of fat. Dose ranges supported by bone and cardiovascular research: D3 at 2,000 to 5,000 IU daily and K2 MK-7 at 100 to 200 mcg daily. Time of day is less important than consistency; morning with breakfast or evening with dinner are equally effective.

Specific dosing notes for athletes:

D3 dose selection: Start at 2,000 IU if you have limited sun exposure, 3,000 to 5,000 IU if testing shows serum 25-OH-D below 30 ng/mL. Avoid exceeding 10,000 IU daily without clinical supervision, as D3 toxicity (hypercalcemia) becomes a risk above this range with long-term use.
K2 MK-7 dose: 100 mcg is the minimum effective dose for cardiovascular MGP carboxylation. 200 mcg is appropriate when taking D3 at 4,000 IU or above, or when bone density is a primary concern.
Serum testing: Test 25-OH-D (the standard vitamin D blood test) before beginning supplementation and retest after 3 months to confirm the dose is adequate. The athlete target range is 40 to 60 ng/mL. Above 100 ng/mL warrants dose reduction.
Fat pairing: Avocado, nuts, olive oil, or any whole-food fat source alongside the supplement is sufficient. Supplements taken with a fat-free meal or on an empty stomach have 30 to 50% lower absorption, based on pharmacokinetic studies comparing fasting vs. fed-state D3 absorption.
Interactions: Warfarin (Coumadin) users should not add K2 without medical supervision, as K2 affects clotting protein carboxylation, which warfarin suppresses.

Do D3 and K2 Give You Energy?

Vitamin D3 and K2 are not direct energy sources and do not stimulate the central nervous system the way caffeine or adaptogens do. Their energy-related benefit is indirect: correcting vitamin D deficiency in athletes who are deficient reliably reduces fatigue and restores training capacity, because D3 is required for mitochondrial respiration and neuromuscular signaling. Athletes who notice improved energy after starting D3 supplementation were almost certainly deficient before, and the improvement reflects restoration of baseline physiology rather than a pharmacological stimulant effect.

This distinction matters when evaluating claims. D3 appears on lists of "vitamins that give you energy" because deficiency correction produces a subjective energy improvement that is often dramatic. A 2013 clinical trial in the Journal of Clinical Endocrinology and Metabolism found that athletes with D deficiency who supplemented to sufficiency over 16 weeks reported significantly reduced perceived fatigue and improved upper and lower body strength compared to placebo. But athletes who are already D-sufficient do not get an additional energy boost from more D3.

K2's contribution to energy is similarly indirect. If K2 is adequate and arterial health is maintained over years, cardiovascular efficiency improves. This does not translate to a noticeable training-day energy effect but is part of the long-term performance and health profile.

For direct performance-day energy and endurance support, the evidence points to compounds like dietary nitrate from beetroot, beta-alanine for buffering, and creatine for ATP resynthesis. D3 and K2 are the foundation that allows those compounds to work on a body with intact muscle function and structural integrity.

Pairing D3 and K2 with Your Performance Stack

Vitamin D3 and K2 address foundational physiology: bone integrity, calcium routing, muscle neuromuscular efficiency, and cardiovascular health over the long training career. They are not performance-acutes; they build the substrate on which performance compounds operate.

Endurance360® covers the key performance loading compounds that work on a complementary timeline: beta-alanine for lactate buffering, creatine for high-intensity repeat efforts, cordyceps and rhodiola for aerobic capacity and recovery adaptation. Adding D3 and K2 as a daily foundational layer alongside a performance-specific supplement creates a complete protocol that addresses both the health infrastructure and the training stimulus.

For athletes evaluating their full supplement stack, D3 and K2 belong in the same category as magnesium and omega-3s: high evidence, low cost, foundational, and irreplaceable by any performance compound. The performance compounds do not compensate for deficiency-driven muscle weakness or stress fracture vulnerability; D3 and K2 do.

Learn more about the performance loading layer at Endurance360® for Endurance Athletes.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before beginning any supplement protocol.

Vitamin D3 and K2 Benefits for Endurance Athletes (2026)